| Current Price | $3.97 | Mkt Cap | $41.1M |
|---|---|---|---|
| Open | $4.09 | P/E Ratio | 0.00 |
| Prev. Close | $3.97 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.80 - $4.09 | Volume | 20 |
| 52-Wk Range | $2.14 - $13.00 | Avg. Daily Vol. | 87,271 |
A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.
| Current Price | $3.97 | Mkt Cap | $41.1M |
|---|---|---|---|
| Open | $4.09 | P/E Ratio | 0.00 |
| Prev. Close | $3.97 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.80 - $4.09 | Volume | 20 |
| 52-Wk Range | $2.14 - $13.00 | Avg. Daily Vol. | 87,271 |
The best Bull and Bear pitches based on recency and number of recommendations.
An injectable ED Drug? Yeah I don't think that's going to work.http://www.thestreet.com/story/11171001/2/biotech-stock-mailbag-ranking-cheap-biotechs.html
Read the most recent pitches from players about PTN.
Recs
LPTIM
(< 20)
Submitted: 2/14/2021 8:06:16 PM :
Start Price:
$4.61
NYSE MKT:PTN Score:
-16.37
MOVING UP FOR SURE
TAKE A LOOK
Recs
sk2129
(34.60)
Submitted: 9/17/2015 11:04:53 AM :
Start Price:
$28.00
NYSE MKT:PTN Score:
-179.31
baker bros
Recs
vzuopsref
(< 20)
Submitted: 8/16/2015 8:52:10 AM :
Start Price:
$27.00
NYSE MKT:PTN Score:
-181.67
Pending FDA approval of competitor's similar drug
Find the members with the highest scoring picks in PTN.
007191 (< 20) Score: +311.25
The Score Leader is the player with the highest score across all their picks in PTN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| 007191 | < 20 | 10/18/2006 |
|
1Y | $68.50 | -94.20% | +217.05% | +311.25 | 0 Comment | |
| Perse1 | < 20 | 2/12/2007 |
|
1Y | $56.25 | -92.94% | +202.23% | +295.17 | 0 Comment | |
| jbwest | 87.21 |
|
|
1Y | $47.00 | -91.55% | +202.00% | +293.56 | 0 Comment | |
| allstar31 | 99.94 | 9/15/2014 |
|
5Y | $23.75 | -83.28% | +105.79% | +189.08 | 1 Comment | |
| bbbensphone | 76.33 | 2/29/2016 |
|
5Y | $12.50 | -68.24% | +110.07% | +178.31 | 0 Comment | |
| Almostperfect1 | 73.44 | 12/23/2022 |
|
5Y | $2.36 | +68.22% | +7.92% | +60.30 | 0 Comment | |
| mn1 | < 20 | 8/31/2022 |
|
5Y | $4.61 | -13.88% | +2.48% | -16.37 | 0 Comment | |
| kfassini | < 20 | 8/31/2022 |
|
5Y | $4.61 | -13.88% | +2.48% | -16.37 | 0 Comment | |
| LPTIM | < 20 | 8/31/2022 |
|
3M | $4.61 | -13.88% | +2.48% | -16.37 | 1 Comment | |
| squidulin | < 20 | 8/31/2022 |
|
5Y | $4.61 | -13.88% | +2.48% | -16.37 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
